# A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects

> **NCT02666196** · PHASE1 · COMPLETED · sponsor: **National University Hospital, Singapore** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DAA-I
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02666196
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666196, "A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered DAA-I in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02666196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*